1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecules
1.2.4 Small Molecule Drug Conjugates
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lymphoma
1.3.3 Melanoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Prostate Cancer
1.3.7 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Cancer Therapy Market Perspective (2017-2028)
2.2 Small Molecule Targeted Cancer Therapy Growth Trends by Region
2.2.1 Small Molecule Targeted Cancer Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Size by Region (2017-2022)
2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2023-2028)
2.3 Small Molecule Targeted Cancer Therapy Market Dynamics
2.3.1 Small Molecule Targeted Cancer Therapy Industry Trends
2.3.2 Small Molecule Targeted Cancer Therapy Market Drivers
2.3.3 Small Molecule Targeted Cancer Therapy Market Challenges
2.3.4 Small Molecule Targeted Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue
3.1.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue (2017-2022)
3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Targeted Cancer Therapy Revenue
3.4 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2021
3.5 Small Molecule Targeted Cancer Therapy Key Players Head office and Area Served
3.6 Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
3.7 Date of Enter into Small Molecule Targeted Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Cancer Therapy Breakdown Data by Type
4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2017-2022)
4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2023-2028)
5 Small Molecule Targeted Cancer Therapy Breakdown Data by Application
5.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2017-2022)
5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2017-2028)
6.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type
6.2.1 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
6.2.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028)
6.2.3 North America Small Molecule Targeted Cancer Therapy Market Share by Type (2017-2028)
6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Application
6.3.1 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
6.3.2 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028)
6.3.3 North America Small Molecule Targeted Cancer Therapy Market Share by Application (2017-2028)
6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Country
6.4.1 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022)
6.4.2 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2017-2028)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type
7.2.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
7.2.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028)
7.2.3 Europe Small Molecule Targeted Cancer Therapy Market Share by Type (2017-2028)
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Application
7.3.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
7.3.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028)
7.3.3 Europe Small Molecule Targeted Cancer Therapy Market Share by Application (2017-2028)
7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Country
7.4.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022)
7.4.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size (2017-2028)
8.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type
8.2.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application
8.3.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region
8.4.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Small Molecule Targeted Cancer Therapy Market Size (2017-2028)
9.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Type
9.2.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Small Molecule Targeted Cancer Therapy Market Share by Type (2017-2028)
9.3 Latin America Small Molecule Targeted Cancer Therapy Market Size by Application
9.3.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Small Molecule Targeted Cancer Therapy Market Share by Application (2017-2028)
9.4 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country
9.4.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size (2017-2028)
10.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type
10.2.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application
10.3.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country
10.4.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 OncoGenex Pharmaceuticals, Inc.
11.1.1 OncoGenex Pharmaceuticals, Inc. Company Details
11.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
11.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Introduction
11.1.4 OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.1.5 OncoGenex Pharmaceuticals, Inc. Recent Developments
11.2 Cytokinetics Inc.
11.2.1 Cytokinetics Inc. Company Details
11.2.2 Cytokinetics Inc. Business Overview
11.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Introduction
11.2.4 Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.2.5 Cytokinetics Inc. Recent Developments
11.3 Hospira Inc.
11.3.1 Hospira Inc. Company Details
11.3.2 Hospira Inc. Business Overview
11.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Introduction
11.3.4 Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.3.5 Hospira Inc. Recent Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.4.5 GlaxoSmithKline plc Recent Developments
11.5 Boehringer Ingelheim GmbH
11.5.1 Boehringer Ingelheim GmbH Company Details
11.5.2 Boehringer Ingelheim GmbH Business Overview
11.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Introduction
11.5.4 Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.5.5 Boehringer Ingelheim GmbH Recent Developments
11.6 Bayer HealthCare AG
11.6.1 Bayer HealthCare AG Company Details
11.6.2 Bayer HealthCare AG Business Overview
11.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Introduction
11.6.4 Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.6.5 Bayer HealthCare AG Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
11.7.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.7.5 Abbott Laboratories Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer